# Gentherm Inc: Form 10-Q for the period ended Mar 31, 2012

- Company: [Gentherm Inc](/companies/thrm.md) (CIK 903129)
- Form: 10-Q
- Filed: 2012-05-08
- Accepted by EDGAR: May 8, 2012, 21:12 ET
- Period: 2012-03-31
- Accession: 0001193125-12-218865
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/903129/000119312512218865/d340567d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/903129/000119312512218865/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2012-01-01 to 2012-03-31 | $97.1m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2012-01-01 to 2012-03-31 | $32.4m | us-gaap:GrossProfit |
| Research and development | 3 months, 2012-01-01 to 2012-03-31 | $10.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2012-01-01 to 2012-03-31 | $14.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2012-01-01 to 2012-03-31 | $8.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2012-01-01 to 2012-03-31 | $2.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2012-01-01 to 2012-03-31 | $4.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2012-01-01 to 2012-03-31 | $0.11 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2012-01-01 to 2012-03-31 | $0.11 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2012-01-01 to 2012-03-31 | 25,151,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2012-01-01 to 2012-03-31 | $6.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2012-01-01 to 2012-03-31 | $3.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2012-03-31 | $100.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-03-31 | $263.1m | us-gaap:AssetsCurrent |
| Total assets | at 2012-03-31 | $465.5m | us-gaap:Assets |
| Current liabilities | at 2012-03-31 | $117.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2012-03-31 | $220.0m | us-gaap:Liabilities |
| Long-term debt | at 2012-03-31 | $58.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2012-03-31 | $15.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2012-03-31 | $155.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 18,082 characters.

### General

The Company designs, develops and markets proprietary technology electronic components and systems for sale to car and truck original equipment manufacturers (“OEMs”). One of the Company’s primary automotive seat comfort products is the Climate Control Seat™ (“CCS™”), which provides year-round comfort by providing both heating and cooling to seat occupants. During the second quarter of 2011, the Company acquired a majority interest in W.E.T. Automotive Systems AG (“W.E.T.”), a developer, manufacturer and distributor of heating systems, interior equipment and accessories used in automobile seats and other automotive and electronic applications in the automotive industry. The activities of W.E.T. represent a significant portion of the Company’s consolidated assets, liabilities, revenues and expenses.

### Results of Operations

#### First Quarter 2012 Compared with First Quarter 2011

The following table presents select operations data for the period as reported, amounts for W.E.T. operations and amounts for Amerigon less the W.E.T. amounts representing the historical portion of Amerigon. These Historical Amerigon financial results, which are non-GAAP measures, are provided to help shareholders understand Amerigon’s results of operations in light of the acquisition of W.E.T. These non-GAAP financial measures should be viewed in addition to, and not as an alternative for, Amerigon’s reported results prepared in accordance with GAAP.

*(In Thousands)*

|  | Three month period ended March 31, 2012 As Reported | Less: W.E.T. | Historical Amerigon | Three month ended March 31,2011 |
| --- | ---: | ---: | ---: | ---: |
| Product revenues | $129,526 | $100,528 | $28,998 | $35,796 |
| Cost of sales | 97,077 | 75,867 | 21,210 | 25,340 |
| Gross margin | 32,449 | 24,661 | 7,788 | 10,456 |
| Gross margin percent | 25.1% | 24.5% | 26.9% | 29.2% |
| Operating expenses: |  |  |  |  |
| Net research and development expenses | 9,759 | 7,395 | 2,364 | 2,469 |
| Acquisition transaction expenses | — | — | — | 3,754 |
| Selling, general and administrative expenses | 13,973 | 9,944 | 4,029 | 3,364 |
| Operating income | 8,717 | 7,322 | 1,395 | 869 |
| Earnings before income tax | 8,509 | 7,789 | 720 | 1,105 |

*Product Revenues*. Product revenues for the three months ended March 31, 2012 (“First Quarter 2012”) were $129,526,000 compared with product revenues of $35,796,000 for the three months ended March 31 2011 (“First Quarter 2011”), an increase of $93,730,000, or 262%, reflecting additional revenue for W.E.T. of $100,528,000. The W.E.T. revenues include the effects of the first historical Amerigon vehicle program to be produced in a W.E.T. facility totaling $7,003,000. The $6,798,000, or 19%, decrease in product revenues attributable to historical Amerigon is primarily the result of the aforementioned program transfer to W.E.T. Sales from this program were approximately $5,700,000 in the First Quarter 2011. Revenues on existing vehicle programs were down approximately $1,400,000 in the First Quarter

2012 compared with the First Quarter 2011, driven by lower sales volumes on Nissan, Hyundai and Kia programs and partially offset by stronger sales volumes on Ford, Chrysler, Jaguar and Land Rover programs. This decrease reflects the effect of pull ahead of orders from customers in Asia to 2011.

*Cost of Sales*. Cost of sales increased to $97,077,000 in the First Quarter 2012 from $25,340,000 in the First Quarter 2011. This increase of $71,737,000, or 283%, is primarily due to the costs of sales of W.E.T. of $75,867,000. The $4,130,000, or 16%, decrease on cost of sale attributable to historical Amerigon is due to lower sales volumes and slightly lower gross profit percentages. The gross profit percentage during the First Quarter 2012 for historical Amerigon was approximately 27% compared with 29% during the First Quarter 2011. This decrease in gross profit was the result of an unfavorable change in product mix.

*Net Research and Development Expenses*. Net research and development expenses increased to $9,759,000 in the First Quarter 2012 from $2,469,000 in the First Quarter 2011, an increase of $7,290,000, or 295%, primarily reflecting net research and development expenses from W.E.T. totaling $7,395,000.

We classify development and prototype costs and related reimbursements as research and development. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.

*Acquisition Transaction Expenses.* We incurred $3,754,000 in fees and expenses associated with the acquisition of W.E.T. during the First Quarter 2011. The acquisition closed in the second quarter of 2011. We did not incur any acquisition transaction expenses during the First Quarter 2012.

*Selling, General and Administrative Expenses*. Selling, general and administrative expenses increased to $13,973,000 in the First Quarter 2012 from $3,364,000 in the First Quarter 2011. This $10,609,000, or 315%, increase is primarily due to the selling, general and administrative expenses of W.E.T. totaling $9,944,000. The remaining increase of $665,000 principally reflects increased wage and benefit costs of approximately $275,000 and higher consulting and audit and legal costs of approximately $400,000.

*Income Tax Expense.* We recorded an income tax expense of $2,244,000 during the First Quarter 2012 representing an effective tax rate of 26% on earnings before income tax of $8,509,000. This effective tax rate was lower than the US Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions. The acquisition transaction expenses of $3,754,000 during the First Quarter 2011 were not deductible and therefore our income tax rate of 37% for that same period did not reflect any related tax benefit. Our estimated effective tax rate for the First Quarter 2011 was 37% before the effect of the acquisition transaction expenses. Our effective tax rate was estimated based upon a forecast of our full year results not including the nondeductible acquisition transaction costs which were reflected separately as a discrete tax item during 2011.

### Liquidity and Capital Resources

The following table represents our cash and cash equivalents and short-term investments which are available for our business operations:

|  | March 31, 2012 | December 31, 2011 |
| --- | ---: | ---: |
| Cash and cash equivalents | $100,601,000 | $23,839,000 |

We manage our cash, cash equivalents in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. Cash and cash equivalents increased by $76,762,000 in the First Quarter 2012.

Cash provided by operating activities during First Quarter 2012 was $6,788,000 and was attributable to net income of $6,265,000, plus non-cash adjustments. Non-cash adjustments included depreciation and amortization of $7,576,000, deferred tax provisions of $920,000, stock compensation of $292,000 and other items. Partially offsetting these was a net increase in net operating assets and liabilities of $5,420,000 and gains on revaluation of financial derivatives of $2,471,000.

As of March 31, 2012, working capital was $146,098,000 as compared to $65,955,000 at December 31, 2011, an increase of $80,143,000, or 122%. This increase is primarily related to a public offering of 5,290,000 shares of common stock totaling $75,547,000, an increase in inventory of $2,498,000, as well the impact of changes in currency exchange rates.

Cash used in investing activities was $3,874,000 during First Quarter 2012, reflecting purchases of property and equipment totaling $3,029,000, cash paid to acquire new patents and patent application filings of $336,000 and cash loaned to an equity investment of $350,000. Purchases of property and equipment for the period are primarily related to expansion of production capacity, as well as replacement of existing equipment.

Cash provided by financing activities was $72,650,000 during First Quarter 2012, reflecting the aforementioned public offering of common stock totaling $75,547,000, excess tax benefit from equity awards of $459,000 and $271,000 in proceeds of Common Stock option exercises. These amounts were partially offset by repayments of borrowings of $3,613,000.

On March 31, 2011, we issued 7,000 shares of our Series C Convertible Preferred Stock (each a “Preferred Share” and, collectively, the “Preferred Shares”) having an initial stated value of $10,000 per Preferred Share, subject to adjustment. We received approximately $64,013,000 in net proceeds from the sale, after deducting placement agent fees and other offering expenses which totaled $5,987,000.

The Series C Convertible Preferred Stock is to be redeemed in nine equal quarterly installments beginning on September 1, 2011 and ending on September 1, 2013 (each, an “Amortization Date”) by 0paying cash, issuing shares of our Common Stock or any combination thereof for $10,000 per Preferred Share plus accumulated and unpaid dividends. Total Series C Convertible Preferred Stock installments made during the three month period ended are as follows (in Thousands):

|  | Installment Payments ($) | Cash ($) | Stock ($) | Stock (shares) |
| --- | ---: | ---: | ---: | ---: |
| Dividend | $1,085 | $55 | $1,030 | 80,165 |
| Principal | 7,780 | — | 7,780 | 603,931 |
| Total | $28,030 | $55 | $8,810 | 684,096 |

We intend to use a portion of the net proceeds from the public offering of common stock until such time as funds are needed to pay our future obligations to holders of our Series C Preferred Stock. These future cash payment obligations, assuming such shares are not earlier converted into shares of common stock by the holders, are approximately as follows:

|  | 2012 | 2013 | Total |
| --- | ---: | ---: | ---: |
| Dividend | $2,345 | $930 | $3,275 |
| Principal | 23,340 | 23,320 | 46,660 |
| Total | $25,685 | $24,250 | $49,935 |

The Company has two outstanding credit agreements with a syndicate of banks led by Bank of America; the US Bank of America credit facility and the W.E.T. Bank of America credit facility. The US Bank of America credit facility consists of the US Term Note and Europe Term Note. These notes are subject to quarterly principal payments, with total principal amortization of 10% of the original principal amount in the first year and amortization of 12.5%, 15%, 17.5% and 20% of the original principal amount during years two, three, four and five, respectively with all remaining amounts owing under each term facility due and payable in full at the term loan maturity date. The W.E.T. Bank of America credit facility consists of the W.E.T. Term Note, which is subject to quarterly principal payments totaling 20% annually. Principal outstanding under both the US Bank of America credit facility and W.E.T. Bank of America credit facility will be due and payable in full on March 30, 2016. Interest is payable at least quarterly. The Company has the option to elect interest rates based on either a Eurocurrency (LIBOR or EUIBOR) rate (“Eurocurrency Rate Loans”) (0.20% – 1.30% at March 31, 2012) or a base rate (“Base Rate Loans”) plus a margin (“Applicable Rate”) which, after an initial period will vary based on the Consolidated Leverage Ratio of the Company, as defined by the US and W.E.T. Bank of America credit agreements. This initial period ended during the fourth quarter of 2011. The base rate is equal to the highest of the Federal Funds Rate (0.09% at March 31, 2012) plus 0.5%, Bank of America’s prime rate (3.25% at March 31, 2012), or a one month Eurocurrency rate plus 1.0%. The Applicable Rate for the current period is 3.0% for Eurocurrency Rate Loans and 2.0% for Base Rate Loans.

The Company must maintain certain financial ratios including a minimum Consolidated Fixed Charge Coverage Ratio and a maximum Leverage Ratio as defined by the Bank of America credit agreement. The loans are secured by all of the Company’s assets.

As of March 31, 2012, we were in compliance with all terms as outlined in the credit agreement for each of the US Bank of America credit facility and the W.E.T. Bank of America credit facility.

The following table summarizes the Company’s debt at March 31, 2012.

|  | Interest Rate | (in thousands) Principal Balance |
| --- | ---: | ---: |
| US Term Note | 3.47% | $32,375 |
| Europe Term Note | 3.69% | 4,547 |
| US Revolving Note | — | — |
| W.E.T. Term Note | 3.67% | 33,542 |
| W.E.T. Revolving Note | — | — |
| Capital Leases | 5.5% | 3,153 |
| Total debt |  | 73,617 |
| Current portion |  | (15,309) |
| Long-term debt, less current maturities |  | $58,308 |

On August 16, 2011, W.E.T. held its annual general assembly meeting during which the W.E.T. shareholders approved the adoption of a Domination and Profit and Loss Transfer Agreement (“DPLTA”). Under the terms of the DPLTA, when the DPLTA is registered, the minority shareholders of W.E.T. will be guaranteed a recurring, annual payment (the “Guaranteed Compensation”) of EUR 3.71 per share of W.E.T. held, subject to statutory taxes and deductions, resulting in a net payment of EUR 3.17 per share beginning in 2012; however, the minority shareholders of W.E.T. can elect to forego the Guaranteed Compensation and instead tender their shares to Amerigon Europe for a one-time cash payment of EUR 44.95 per share after the agreement is registered. If all minority shareholders of W.E.T. tendered their shares, the total payment obligation of Amerigon Europe would be approximately EUR 33,139,000.

A minority shareholder of W.E.T. has filed an action in Germany to set aside the shareholder approval of the DPLTA based on alleged violations of German corporate law. As a result, the DPLTA has not yet been registered and will not go into effect until the minority shareholder action is resolved.

In order to provide financing for the potential tender offer to the minority shareholders of W.E.T., the Company entered into an amendment to the US Bank of America credit facility, on October 28, 2011. The amendment provides for a $45,000,000 term loan facility for Amerigon Europe which replaced Amerigon Europe’s then existing Europe Term Note. As of March 31, 2012 €3,409,000, or $4,547,000, was outstanding under this term loan facility and $40,453,000 was available for future borrowing. Amerigon Europe is permitted to access this additional term loan financing in one or more draws through no later than January 1, 2013, and the proceeds of such draws may only be used by Amerigon Europe to fund the potential tender of shares of W.E.T. in connection with the DPLTA.

The Company has funded its financial needs from inception primarily through net proceeds received through its initial public offering as well as other equity and debt financing activities. Based on its current operating plan, management believes cash and equivalents at March 31, 2012 along with proceeds from future revenues are sufficient to meet operating needs for the foreseeable future.

### Recent Accounting Pronouncement

*Disclosures about Offsetting Assets and Liabilities.* In December 2011, the FASB issued ASU No. 2011-11 which amends Topic 210 (Balance Sheet). ASU No. 2011-11 is intended to enhance the disclosure requirements for offsetting (netting) assets and liabilities and the effect or potential effect on an entity’s financial position, including the effect or potential effect of rights of setoff associated with certain financial and derivative instruments. The amendments in ASU No. 2011-11 include quantitative disclosure requirements to be presented in tabular format. The tabular disclosure components are as follows:

f) the gross amounts of those recognized assets and those recognized liabilities,

g) the amounts offset in order to determine the net amounts presented in the statement of financial position,

h) the net amounts presented in the statement of financial position,

i) the amounts subject to an enforceable master netting arrangement, if applicable, and

j) the net amount after deducting the amounts in (d) from the amounts in (c).

ASU No. 2011-11 is to be applied retrospectively upon adoption and is effective for annual periods beginning on or after January 1, 2013, and interim periods within those annual periods. While the adoption of ASU No. 2011-11 is not expected to have a material impact on our consolidated condensed financial statements, it could expand our disclosures around certain financial and derivative instruments.

### FORWARD LOOKING STATEMENTS

Certain matters discussed or referenced in this report, including expectations of increased revenues and continuing losses, our financing requirements, our capital expenditures, our potential acquisitions and our prospects for the development of platforms with major automotive manufacturers, are forward-looking statements. Other forward-looking statements may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “anticipate”, “intend”, “continue”, or similar terms, variations of such terms or the negative of such terms. All forward-looking statements speak only as of the date of this report, and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this report to reflect any change in our expectations with regard to such statements or any change in events, conditions or circumstances on which any such statement is based. Although such statements are based upon our current expectations, and we believe such expectations are reasonable, such expectations, and the forward-looking statements based on them, are subject to a number of factors, risks and uncertainties that could cause our actual results to differ materially from those described in the forward-looking statements, including those described below and in our other filings with the Securities and Exchange Commission (“SEC”).

## Market risk

As filed, 11,017 characters.

Our exposure to market risk for changes in interest rates relates primarily to our debt obligations under our Bank of America credit facilities and foreign currency contracts. We have in the past, and may again in the future, place our investments in bank certificates of deposits, debt instruments of the U. S. government, and in high-quality corporate issuers.

Our purchases of certain components are denominated in Japanese Yen. In order to protect ourselves from changes in the exchange rate between the U.S. Dollar and Japanese Yen, we periodically enter into foreign currency forward contracts to purchase the Japanese Yen. As of March 31, 2012 we had no open forward currency contracts.

Our subsidiary, W.E.T., is exposed to market risk from changes in foreign currency exchange rates, short term interest rates and price fluctuations of certain material commodities such as copper. Foreign currency exchange risks are attributable to sales to foreign customers not denominated in the seller’s functional currency, foreign plant operations, intercompany indebtedness and purchases from foreign suppliers and include exposures to the European Euro, Canadian Dollar, and Mexican Peso. W.E.T. regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from this risk by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. While W.E.T. continuously monitors the hedging program, derivative positions and hedging strategies and maintains documentation as to the hedging objectives, practices and procedures, W.E.T. has not typically designated its derivatives as hedging instruments for accounting purposes.

In March 2008, W.E.T. entered into a 10 year currency related interest rate swap (“CRS”) having a notional value of €10,000,000 or $13,338,000 as of March 31, 2012, in order to offset the interest rate risk associated with a debt financing which was repaid prior to our acquisition of W.E.T. Under this agreement W.E.T. receives interest equal to the then six month Euro Interbank Offered Rate (“EURIBOR”), 1.08% at March 31, 2012, plus 1.40% and pays interest equal to the six month EUIBOR when the exchange rate between the European Euro (“EUR”) and the Swiss Franc (“CHF”), which was 1.21 at March 31, 2012, equals or exceeds 1.46 EUR to the CHF or pays interest equal to the six month EURIBOR plus a premium when this exchange rate is less than 1.46. The premium is calculated as \[(1.46 – current EUR/CHF rate)/current EUR/CHF rate\] x 100. W.E.T. has entered into offsetting derivative contracts that cancel out the payment due under the CRS through 2012.

In July 2011, the Company entered into a series of interest rate swap contracts and a interest rate cap agreement designated as cash flow hedges in order to hedge the exposure to variable market interest rates on the Company’s senior debt. Gains and losses reported in accumulated other comprehensive income will be reclassified to earnings once the Company’s senior debt is repaid. Information on the interest rate swap contracts is as follows:

| Contract Type | Contract Term | (in thousands) Notional Value | Hedged Instruments | Fixed Rate | Variable Rate | Rate Cap |
| --- | --- | ---: | --- | ---: | --- | ---: |
| Swap | June 30, 2014 | $8,000 | US Term Note | 1.27% | 3 month LIBOR | — |
| Swap | June 30, 2014 | $8,000 | US Term Note | 1.27% | 3 month LIBOR | — |
| Cap | March 31, 2016 | €14,250 | W.E.T. Term Note | — | 3 month EURIBOR | 2.75 |

24

Information related to the fair values of derivative instruments in our consolidated balance sheet as of March 31, 2012 is as follows:

|  | Hedge Designation | Fair Value Hierarchy | Asset Derivatives Balance Sheet Location | Fair Value | Liability Derivatives Balance Sheet Location | Fair Value | Net Asset/ (Liabilities) |
| --- | --- | --- | --- | ---: | --- | ---: | ---: |
| CRS | Not a hedge | Level 2 |  |  | Current liabilities | $(2,759) |  |
|  |  |  |  |  | Non current liabilities | (16,011) |  |
| Total CRS |  | Level 2 |  |  |  | $(18,770) | $(18,770) |
| Foreign currency derivatives | Not a hedge | Level 2 | Current assets | $1,795 | Current liabilities | $(489) | $1,306 |
| Interest rate swap derivatives | Cash flow hedge | Level 2 |  |  | Current liabilities | $(239) | $(239) |
| Commodity derivatives | Not a hedge | Level 2 |  |  | Current liabilities | $(20) | $(20) |

Information related to the effect of derivative instruments on our consolidated income statements is as follows:

|  | Location | Three Month Ended March 31, 2012 | Three Month Ended March 31, 2011 |
| --- | --- | ---: | ---: |
| Foreign currency derivatives | Revaluation of derivatives | $1,087 | $3 |
|  | Foreign currency gain (loss) | 897 | — |
| Total foreign currency derivatives |  | $1,984 | $3 |
| CRS | Revaluation of derivatives | $147 | $— |
| Commodity derivatives | Revaluation of derivatives | $126 | $— |
| Interest Rate Swap | Interest Expense | $(28) | $— |
|  | Other Comprehensive Income | (33) | — |

#### Interest Rate Sensitivity

The table below provides information about the Company’s derivative financial instruments and other financial instruments that are sensitive to changes in interest rates, including interest rate swaps and debt obligations. For debt obligations, the table presents principal cash flows and related weighted average interest rates by expected maturity dates. For interest rate swaps, the table presents notional amounts and weighted average interest rates by expected (contractual) maturity dates. Notional amounts are used to calculate the contractual payments to be exchanged under the contract. Weighted average variable rates are based on implied forward rates in the yield curve at the reporting date. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in both U.S. dollars ($USD) and European Euros (€EUR), as indicated in parentheses.

### March 31, 2012

*(In Thousands except rate information)*

| Liabilities Long Term Debt: | Expected Maturity Date 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | Total | Fair Value |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Fixed Rate (€EUR) | $2,089 | $1,064 | $— | $— | $— | $— | $— | $3,153 | $3,153 |
| Average Interest Rate | 5.50% | 5.50% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.50% |  |
| Variable Rate ($USD) | $3,063 | $4,813 | $5,687 | $6,562 | $12,250 | $— | $— | $32,375 | $32,375 |
| Average Interest Rate | 3.47% | 3.47% | 3.47% | 3.47% | 3. 47% | 0.00% | 0.00% | 3. 47% |  |
| Variable Rate (€EUR) | $6,379 | $8,641 | $8,756 | $8,872 | $5,441 | $— | $— | $38,089 | $38,089 |
| Average Interest Rate | 3.68% | 3.68% | 3.68% | 3.68% | 3.68% | 0.00% | 0.00% | 3.68% |  |
| Derivative Financial Instruments: |  |  |  |  |  |  |  |  |  |
| Interest Rate Swap ($USD) | $63 | $49 | $6 | $— | $— | $— | $— | $118 | $118 |
| Average Interest Rate | 0.49% | 0.67% | 0.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% |  |
| Interest Rate Swap ($USD) | $63 | $50 | $8 | $— | $— | $— | $— | $121 | $121 |
| Average Interest Rate | 0.49% | 0.65% | 0.88% | 0.00% | 0.00% | 0.00% | 0.00% | 0.60% |  |
| Interest Rate Cap (€EUR) | $— | $— | $— | $— | $19 | $— | $— | $19 | $19 |
| Average Interest Rate | 0.00% | 0.00% | 0.00% | 0.00% | 1.71% | 0.00% | 0.00% | 1.71% |  |

#### Exchange Rate Sensitivity

The table below provides information about the Company’s derivative financial instruments, other financial instruments by functional currency and presents such information in U.S. dollar equivalents. The table summarizes information on instruments and transactions and are sensitive to foreign currency exchange rates, including foreign currency forward exchange agreements, €EUR denominated debt obligations and Chinese Yuan (¥ CNY) denominated debt obligations. For debt obligations, the table presents principal cash flows and related weighted average interest rates by expected maturity dates. For foreign currency forward exchange agreements, the table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

### March 31, 2012

*(In Thousands except rate information)*

| Anticipated Transactions And Related Derivatives Euro functional currency Forward Exchange Agreements: (Receive USD$/Pay EUR€) | Expected Maturity or Transaction Date 2012 | 2013 | 2014 | 2015 | 2016 | Thereafter | Total | Fair Value |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total Contract Amount(€) | €7,052 | €4,327 |  |  |  |  | €11,379 | €(106) |
| Average Contract Rate | 1.3195 | 1.3867 | — | — | — | — | 1.3459 |  |
| (Receive HUF/Pay EUR€) |  |  |  |  |  |  |  |  |
| Total Contract Amount (€) | €6,209 |  |  |  |  |  | €6,209 | €(226) |
| Average Contract Rate | 288.28 | — | — | — | — | — | 288.28 |  |
| (Receive CHF/Pay EUR) |  |  |  |  |  |  |  |  |
| Total Contract Amount (€) | €5,126 |  |  |  |  |  | €5,126 | €834 |
| Average Contract Rate | 1.4400 | — | — | — | — | — | 1.4400 |  |
| (Receive KRW/Pay EUR€) |  |  |  |  |  |  |  |  |
| Total Contract Amount (€) | €1,689 |  |  |  |  |  | €1,689 | €30 |
| Average Contract Rate | 1,495.40 |  |  |  |  |  | 1,495.40 |  |
| **$US functional currency** |  |  |  |  |  |  |  |  |
| **Forward Exchange Agreements:** |  |  |  |  |  |  |  |  |
| (Receive USD$/Pay CAD$) |  |  |  |  |  |  |  |  |
| Total Contract Amount ($) | $7,564 |  |  |  |  |  | $7,564 | $142 |
| Average Contract Rate | 1.0179 | — | — | — | — | — | 1.0179 |  |
| (Receive USD$/Pay JPY¥) |  |  |  |  |  |  |  |  |
| Total Contract Amount ($) | $4,223 |  |  |  |  |  | $4,223 | $(46) |
| Average Contract Rate | 81.6917 | — | — | — | — | — | 81.6917 |  |
| (Receive USD$/Pay MXN) |  |  |  |  |  |  |  |  |
| Total Contract Amount ($) | $5,285 |  |  |  |  |  | $5,285 | $236 |
| Average Contract Rate | 13.4347 | — | — | — | — | — | 13.4347 |  |

27

#### Commodity Price Sensitivity

The table below provides information about the Company’s futures contracts that are sensitive to changes in commodity prices, specifically copper prices. For the futures contracts the table presents the notional amounts in metric tons (MT), the weighted average contract prices, and the total dollar contract amount by expected maturity dates. Contract amounts are used to calculate the contractual payments and quantity of copper to be exchanged under the futures contracts.

### December 31, 2011

| On Balance Sheet Commodity Position and Related Derivatives Related Derivatives Futures Contracts ( ): | Carrying Amount Expected Maturity 2012 | Fair Value Fair Value |
| --- | ---: | ---: |
| Contract Volumes (metric tons) | 40 |  |
| Weighted Average Price (per metric ton) | $8,800 |  |
| Contract Amount ($) | $880,000 | (21) |

## Controls and procedures

As filed, 2,732 characters.

### (a) Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2012. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of the end of the period covered by our Quarterly Report on Form 10-Q, in light of the material weakness in Internal Control over Financial Reporting described below, our disclosure controls and procedures were not effective to provide reasonable assurance that the information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

As disclosed in our Annual Report on Form 10-K, management previously concluded that our internal control over financial reporting was not effective based upon the framework in “Internal Control—Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission. Management identified a material weakness in accounting for significant, non-routine transactions. Although there were no such significant, non-routine transactions during the three month period ended March 31, 2012, we are working to remediate our material weakness in accounting for significant, non-routine transactions by hiring additional highly skilled accountants. Our remediation efforts are likely to be more difficult and costly than they otherwise would be if we were able to register a Domination and Profit and Loss Transfer agreement with our 76% owned subsidiary, W.E.T. Automotive AG. See PART II, ITEM 1., Legal Proceedings, for more information on our efforts to register a Domination and Profit and Loss Transfer agreement.

Notwithstanding the material weakness described above, we have performed additional analyses and other procedures to enable management to conclude that our consolidated financial statements included in this report were prepared in accordance with accounting principles generally accepted in the United States of America.

### (b) Changes in Internal Control over Financial Reporting

During the fiscal quarter ended March 31, 2012, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 146 characters.

There were no material changes in our risk factors previously disclosed in Part I, Item 1A. of our Form 10-K for the year ended December 31, 2011.

Filed May 8, 2012.
Source: SEC EDGAR, the filing index for accession 0001193125-12-218865. Last ingested by Listed: Oct 26, 2026, 17:44 ET. No prices; not investment advice.
